Skip to content

Chaixiong Zhitong Decoction in the treatment of chronic tension headache of qi-stagnation and blood-stasis: a single-center, double-blind, randomized controlled trial.

Chaixiong Zhitong Decoction in the treatment of chronic tension headache of qi-stagnation and blood-stasis: a single-center, double-blind, randomized controlled trial.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004491
Enrollment
Unknown
Registered
2021-02-27
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic tension headache

Interventions

Sponsors

Chengdu University of Traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Subjects who met the diagnostic criteria of Western medicine and qi stagnation and blood stasis syndrome of traditional Chinese medicine; 2. Subjects of any gender, aged 18-65 years old; 3. Subjects with history of headache, whose pain time was less than 72 hours; 4. Subjects who have been educated for more than 6 years and can keep headache diary for 6 weeks; 5. Subjects with informed consent, volunteers.

Exclusion criteria

Exclusion criteria: 1. Patients with abnormal IL-1 and CRP or undergoing anti-inflammatory treatment; 2. Patients who are using antiplatelet drugs, anticoagulants, statins or hormones; 3. Patients with severe organic diseases, including malignant tumor, tuberculosis, fracture, osteomyelitis, etc; 4. Patients with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; 5. Patients with severe mental disorder and mental retardation who can't cooperate; 6. Patients who need to be hospitalized; 7. Patients with bleeding tendency, allergic constitution and skin diseases; 8. Pregnant women and lactating women, and those who have fertility requirements in the past six months; 9. Subjects who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Headache integral;

Secondary

MeasureTime frame
Rating scale of TCM Syndrome;HIT-6;

Countries

China

Contacts

Public ContactYang Xuhong

Chengdu University of Traditional Chinese medicine

xuhong7506@163.com+86 13881827892

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026